Mursla Company
Novel tech platform to trace tumours early in the blood via cancer-specific exosomes.
Employee Number:
11-50
Funding Status:
Seed
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Technology:
Сancer Diagnostics
Estimated Revenue:
$1M to $10M
Founded Date:
01.08.2017
Last Funding Type:
Seed
Investor Type:
Company
Total Funding:
$2M
Number Of Exists:
Seed
Investment Stage:
N/A
Industry:
Deep Diagnostics